Arcosa, Inc. (FRA:EOB)
Germany · Delayed Price · Currency is EUR 76.00
-1.50 (-1.94%)
At close: Jul 29, 2025, 10:00 PM CET
Intra-Cellular Therapies Market Cap
Arcosa has a market cap or net worth of €3.54 billion as of August 1, 2025. Its market cap has decreased by -11.25% in one year.
Market Cap
3.54B
Enterprise Value
4.91B
Revenue
2.41B
Ranking
n/a
PE Ratio
49.14
Stock Price
$76.00
Market Cap Chart
Since October 30, 2018, Arcosa's market cap has increased from 901.93M to 3.54B, an increase of 292.17%. That is a compound annual growth rate of 22.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.54B | -22.39% |
| Dec 31, 2024 | 4.56B | 25.53% |
| Dec 29, 2023 | 3.63B | 47.68% |
| Dec 30, 2022 | 2.46B | 9.78% |
| Dec 31, 2021 | 2.24B | 3.50% |
| Dec 31, 2020 | 2.16B | 12.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 294.64B |
| Siemens Aktiengesellschaft | 178.07B |
| Deutsche Telekom AG | 154.90B |
| Allianz SE | 131.98B |
| Siemens Energy AG | 80.60B |
| Rheinmetall AG | 79.52B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.53B |
| Deutsche Bank Aktiengesellschaft | 55.92B |